Immunogenicity, efficacy and adverse events of adalimumab in RA patients (Q79151701)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 September 2006

edit

Language	Label	Description	Also known as
English	Immunogenicity, efficacy and adverse events of adalimumab in RA patients	scientific article published on 28 September 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

title

Immunogenicity, efficacy and adverse events of adalimumab in RA patients (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

main subject

adalimumab

1 reference

based on heuristic

inferred from title

author name string

Niko K Bender

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

Christoph E Heilig

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

Benjamin Dröll

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

Jessica Wohlgemuth

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

Franz-Paul Armbruster

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

Bernhard Heilig

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

publication date

28 September 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

published in

Rheumatology International

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

volume

27

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

page(s)

269-274

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

cites work

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-alpha

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept as monotherapy in patients with psoriasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17006705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00296-006-0183-7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

Dimensions Publication ID

1028904873

0 references

PubMed publication ID

17006705

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17006705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

19 December 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79151701&oldid=2220666879"